Literature DB >> 12118170

Innate immunity in host-microbial interactions: beyond B27 in the spondyloarthropathies.

César Pacheco-Tena1, Xiang Zhang, Millicent Stone, Ruben Burgos-Vargas, Robert D Inman.   

Abstract

The spondyloarthropathies are diseases influenced by genetic predisposition and, to a varying extent, infectious triggers. A causal role for bacterial infections is most clear for reactive arthritis. Recent insights into arthritogenic components of bacteria may set the stage for a better understanding of disease pathogenesis, the role of heat shock proteins in antigen processing and immune activation, and the adjuvant effect of CpG-DNA. Recent developments in the area of innate immunity broaden current concepts of genetically defined factors in host-pathogen interactions. In particular, the biology of toll-like receptors as important elements in the innate immune response to pathogens is being defined. These factors in innate immunity may have important implications for sequelae of infections, such as reactive arthritis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12118170     DOI: 10.1097/00002281-200207000-00007

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  3 in total

1.  Aberrant TNF secretion by whole blood in healthy subjects with a history of reactive arthritis: time course in adherent and non-adherent cultures.

Authors:  K Anttonen; A Orpana; M Leirisalo-Repo; H Repo
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

2.  Increased production of soluble CTLA-4 in patients with spondylarthropathies correlates with disease activity.

Authors:  Eric Toussirot; Philippe Saas; Marina Deschamps; Fabienne Pouthier; Lucille Perrot; Sylvain Perruche; Jacqueline Chabod; Pierre Tiberghien; Daniel Wendling
Journal:  Arthritis Res Ther       Date:  2009-07-01       Impact factor: 5.156

3.  The Importance of HLA-B27 in the Evolution of Reactive Arthritis.

Authors:  S Bănicioiu-Covei; A F Vreju; A Rosu; P L Ciurea
Journal:  Curr Health Sci J       Date:  2019-12-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.